Cite

HARVARD Citation

    Wang, H. et al. (2021). Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells. Clinical and translational medicine. 11 (10), p. n/a. [Online]. 
  
Back to record